Chargement en cours...
Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use
BACKGROUND: Ipilimumab and vemurafenib have both been shown to improve survival in phase III trials of patients with metastatic melanoma. Although vemurafenib is associated with a rapid onset of activity, responses are often of limited duration. Conversely, responses to ipilimumab take time to devel...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3464706/ https://ncbi.nlm.nih.gov/pubmed/22640478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-10-107 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|